Search

Your search keyword '"Tumscitz, Carlo"' showing total 184 results

Search Constraints

Start Over You searched for: Author "Tumscitz, Carlo" Remove constraint Author: "Tumscitz, Carlo"
184 results on '"Tumscitz, Carlo"'

Search Results

1. Transcatheter aortic‐valve implantation with or without on‐site cardiac surgery: The TRACS trial

2. Minimalistic Hybrid Approach for the Percutaneous Treatment of Coronary Chronic Total Occlusions: Midterm Follow-Up of an International Multicenter Cohort

5. QFR-Based Virtual PCI or Conventional Angiography to Guide PCI: The AQVA Trial

6. Impact of trans-stent gradient on outcome after PCI: results from a HAWKEYE substudy

7. Radial vs Femoral Access in ACS Patients Undergoing Complex PCI Is Associated With Consistent Bleeding Benefit and No Excess of Risks

8. Ticagrelor Monotherapy Versus Dual-Antiplatelet Therapy After PCI: An Individual Patient-Level Meta-Analysis

9. Impact of recruitment and retention on all-cause mortality in a large all-comers randomised controlled trial: insights from the GLOBAL LEADERS trial

10. Ticagrelor plus aspirin for 1 month, followed by ticagrelor monotherapy for 23 months vs aspirin plus clopidogrel or ticagrelor for 12 months, followed by aspirin monotherapy for 12 months after implantation of a drug-eluting stent: a multicentre, open-label, randomised superiority trial

11. Impact of Sex on Comparative Outcomes of Radial Versus Femoral Access in Patients With Acute Coronary Syndromes Undergoing Invasive Management: Data From the Randomized MATRIX-Access Trial

12. Complete or Culprit-Only PCI in Older Patients with Myocardial Infarction

13. Wire‐based antegrade dissection re‐entry technique for coronary chronic total occlusions percutaneous revascularization: Experience from the ERCTO Registry

14. Impact of trans-stent gradient on outcome after PCI: results from a HAWKEYE substudy

16. Coronary access following ACURATE neo implantation for transcatheter aortic valve-in-valve implantation: Ex vivo analysis in patient-specific anatomies

17. PRECISE-DAPT score for bleeding risk prediction in patients on dual or single antiplatelet regimens:Insights from the GLOBAL LEADERS and GLASSY

20. Ticagrelor Monotherapy or Dual Antiplatelet Therapy After Drug‐Eluting Stent Implantation: Per‐Protocol Analysis of the GLOBAL LEADERS Trial

21. 448 Comparison of quantitative flow ratio, Pd/Pa, and diastolic hyperaemia-free ratio vs. fractional flow reserve in non-culprit lesion of patients with non-ST-segment elevation myocardial infarction

23. Comparison of Investigator-Reported and Clinical Event Committee-Adjudicated Outcome Events in GLASSY

24. Tailoring Treatment with Tirofiban in Patients Showing Resistance to Aspirin and/or Resistance to Clopidogrel (3T/2R). Rationale for the Study and Protocol Design

25. Safety, efficacy and impact on frailty of mini-invasive radial balloon aortic valvuloplasty

26. Comparison of Investigator-Reported and Clinical Event Committee–Adjudicated Outcome Events in GLASSY

27. Comparison of quantitative flow ratio, Pd/Pa and diastolic hyperemia‐free ratio versus fractional flow reserve in non‐culprit lesion of patients with non ST ‐segment elevation myocardial infarction

28. PRECISE-DAPT score for bleeding risk prediction in patients on dual or single antiplatelet regimens: insights from the GLOBAL LEADERS and GLASSY

33. Efficacy and safety of intracoronary epinephrine versus conventional treatments alone in STEMI patients with refractory coronary no‐reflow during primary PCI: The RESTORE observational study

35. Randomized comparison of 6- versus 24-month clopidogrel therapy after balancing anti-intimal hyperplasia stent potency in all-comer patients undergoing percutaneous coronary intervention: Design and rationale for the PROlonging Dual-antiplatelet treatment after Grading stent-induced Intimal hyperplasia study (PRODIGY)

37. Impact of recruitment and retention on all-cause mortality in a large all-comers randomised controlled trial: insights from the GLOBAL LEADERS trial

38. Ticagrelor Alone Versus Dual Antiplatelet Therapy From 1 Month After Drug-Eluting Coronary Stenting

40. TCT-478 Results of the Italian Multicenter Register of the Safety and Feasibility of Transradial Mini-Invasive Balloon Aortic Valvuloplasty (Softly II)

41. Impact of long-term ticagrelor monotherapy following 1-month dual antiplatelet therapy in patients who underwent complex percutaneous coronary intervention: insights from the Global Leaders trial

42. Validation of the updated logistic clinical SYNTAX score for all-cause mortality in the GLOBAL LEADERS trial

44. Rationale and design of a prospective substudy of clinical endpoint adjudication processes within an investigator-reported randomised controlled trial in patients with coronary artery disease: the GLOBAL LEADERS Adjudication Sub-StudY (GLASSY)

45. PRECISE-DAPT score for bleeding risk prediction in patients on dual or single antiplatelet regimens: insights from the GLOBAL LEADERS and GLASSY

49. Efficacy and safety of intracoronary epinephrine versus conventional treatments alone in STEMI patients with refractory coronary no‐reflow during primary PCI: The RESTORE observational study.

Catalog

Books, media, physical & digital resources